Drugs / Clostridium Botulinum A Toxin
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02882893 | Aug 2016 → Jan 2017 | — | Daewoong Pharmaceutical Co. LTD. | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03184363 | Jul → Oct 2017 | — | Daewoong Pharmaceutical Co. LTD. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clostridium Botulinum A Toxin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02882893 ↗ |